NVGCT

The aim of the Netherlands Society of Gene & Cell Therapy is to promote both fundamental and translational research on gene & cell therapies. By bringing together all stakeholders (i.e. researchers, patients, physicians, government and regulatory authorities) the society aims to contribute to the swift development of new therapies for life-threatening diseases, including inherited diseases as well as acquired diseases such as cancer and cardiovascular diseases.

To achieve this, the society actively promotes:

  • Exchange of information and expertise between the various stakeholders
  • Public awareness of the status and possibilities of gene & cell therapy by organizing public events, workshops and lectures
  • Educational & Research-oriented sessions for researchers in the gene & cell therapy field (e.g. organisation of Spring Symposium)

Calendar

News

Winnaars Young Investigator Award 2022 bekend gemaakt – ZonMw

Tijdens het jaarlijkse NVGCT symposium van de Nederlandse Vereniging voor Gen- & Celtherapie (NVGCT) zijn voor de vierde keer de winnaars van de ZonMw Young Investigator Award 2022 bekend gemaakt. Het symposium vond plaats op woensdag 15 en donderdag 16 juni in het congrescentrum “De Werelt” in Lunteren. Source: Winnaars Young Investigator Award 2022 bekend …

Vacancy: Technician Vector Analytics and Production @ MeiraGTx

Company MeiraGTx Netherlands is an Amsterdam based biopharmaceutical company developing local gene therapy for different indications. The company specializes in the development of viral gene therapy vectors, in particular adeno-associated virus (AAV) based therapeutics. Several product candidates are in the discovery and development phase. In our programs, we collaborate with world leading scientists. Position MeiraGTx …

Our Sponsors